Rinvoq ER 30 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F1R36
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,584
Award facts
- Contract value 100% obligated
- $17,583.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 23, 2025, for the supply of RINVOQ ER 30 mg tablets in quantities of 30 units. This $17,583.61 firm fixed-price delivery order is competitively awarded with no set-aside designation and carries an ultimate completion date of December 24, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, maintains extensive federal contract relationships primarily with the Defense Logistics Agency and the Defense Health Agency. The company's contract portfolio demonstrates consistent capability to supply diverse pharmaceutical products and medical supplies to support military and veteran healthcare systems through competitive procurement processes. The underlying IDC represents a strategic acquisition approach enabling flexible and comprehensive pharmaceutical support across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and related medical supplies for defense healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F1R36?
SPE2DR26F1R36 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 23, 2025.
How much is contract SPE2DR26F1R36 worth?
The government has obligated $17,584 on SPE2DR26F1R36.
Is contract SPE2DR26F1R36 an order under another contract?
Yes. SPE2DR26F1R36 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1R36 competed?
The extent of competition for SPE2DR26F1R36 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award